Antimicrobial Photodynamic Therapy in the Control of COVID-19

Antimicrobial Photodynamic Therapy in the Control of COVID-19

Maria G. P. M. S. Neves, Adelaide Almeida, M. Amparo F. Faustino

Antimicrobial photodynamic therapy (aPDT), using well known, safe and cost-effective photosensitizers, such as phenothiazines, e.g., methylene blue (MB), or porphyrins, e.g., protoporphyrin-IX (PP-IX), might help to mitigate the COVID-19 either to prevent infections or to develop photoactive fabrics (e.g., masks, suits, gloves) to disinfect surfaces, air and wastewater, under artificial light and/or natural sunlight.

2020

disinfection, control, coronaviruses, Antimicrobial photodynamic therapy, SARS-CoV-2, COVID-19

DOI: 10.3390/antibiotics9060320

Antibiotics

MDPI AG

Therapeutics. Pharmacology